Anduril IPO 2026: $61B Valuation, Defense Tech Disruption & When Palmer Luckey's Company Goes Public

Anduril is the most anticipated defense IPO in a generation. A $61 billion private valuation, $2.2 billion in 2025 revenue, a $20 billion Army contract, and a founder who built Oculus VR before turning 22. The question is not whether Anduril goes public — it is when and at what price.

But here is the thing: no S-1 has been filed. No underwriters have been named. No date has been set. Palmer Luckey says the company will "definitely" go public. CEO Brian Schimpf says it would be "bad to IPO in the middle of a hype cycle." Those two statements tell you everything about where Anduril sits right now — a company that knows it will be enormous on the public markets and is trying to pick the moment when the valuation sticks rather than deflates. Here is the full picture.

What Anduril Does — and Why It Is Not Lockheed Martin

Anduril Industries builds autonomous defense systems — drones, surveillance towers, underwater vehicles, and AI-powered weapons platforms — tied together by a central AI operating system called Lattice OS. That platform is the connective tissue: it fuses sensor data, automates threat detection, and enables operators to control swarms of autonomous systems from a single interface.

The crucial difference between Anduril and legacy defense contractors is the business model. Lockheed Martin, Raytheon, and Northrop Grumman operate primarily on cost-plus contracts — the government defines what it wants, the contractor builds it, and bills time and materials plus a margin. Anduril flips this: it builds products with its own R&D capital and sells finished systems. That is a Silicon Valley product model applied to defense, and it is why venture capital has poured billions into the company.

Valuation and Funding History

Anduril's funding trajectory is one of the steepest in venture history. The company roughly doubled its valuation from ~$30.5 billion to $61 billion in approximately one year — a pace that is almost unheard of for a company already measured in tens of billions.

The $20 Billion Army Contract That Changed the Conversation

On March 13, 2026, the US Army awarded Anduril a $20 billion, 10-year enterprise contract — one of the largest defense technology contracts ever given to a non-traditional contractor. The deal covers autonomous systems, counter-drone technology, and AI-powered command infrastructure across multiple Army programs.

That contract alone would justify an IPO. It provides a revenue baseline that makes Anduril's financial story legible to public market investors who need predictable cash flows. Combined with the company's existing ~$2.2 billion in 2025 revenue and its target of $4.3 billion in 2026 revenue, the growth trajectory is striking — nearly doubling year over year at a scale where most defense companies grow in single digits.

Sources: Company disclosures, Bloomberg, Reuters, Defense News. Track this and other upcoming IPOs on the IPO Tracker.

Key Products: What Anduril Actually Builds

Anduril is not a single-product company. It operates across air, land, sea, and cyber domains. Here are the systems that generate the revenue and win the contracts.

The key strategic asset is Arsenal-1 — Anduril's new weapons manufacturing facility designed for mass production of autonomous systems. Palmer Luckey has said the IPO will come "after Arsenal-1 can deliver at scale," making it both an operational milestone and an IPO trigger.

Palmer Luckey: From Oculus to the Pentagon

Palmer Luckey founded Oculus VR at age 19 in 2012 and sold it to Facebook for $2 billion in 2014. He was fired from Facebook in 2017 — reportedly over political donations — and immediately started Anduril with a thesis that the US military was catastrophically behind on software and autonomy.

That instinct has proven correct. Luckey is the founder and public face of Anduril, but Brian Schimpf — a co-founder and former Palantir executive — serves as CEO and runs day-to-day operations. The Luckey-Schimpf dynamic is key to the IPO calculus: Luckey generates attention and evangelizes the vision, while Schimpf manages the Pentagon relationships and operational scaling that a public company investor base will scrutinize.

Luckey's track record matters for the IPO. He has done this before — built a company, scaled it, and taken it through a major liquidity event. Investors who backed Oculus made enormous returns. The Anduril IPO, whenever it comes, will carry that same founder premium that only a handful of defense company leaders can command.

Why Anduril Has Not Filed Yet

CEO Brian Schimpf has been explicit: he thinks it is "bad to IPO in the middle of a hype cycle." That is a revealing statement. Defense tech is the hottest sector in venture capital right now. Government budgets are expanding. AI-powered autonomy is the dominant narrative. Every condition screams "go public now" — and Anduril is choosing not to.

There are several reasons this makes sense. First, the company just raised $5 billion in private capital. It does not need public market money. Second, staying private lets Anduril avoid quarterly earnings pressure while it scales Arsenal-1 and ramps manufacturing. Third, if defense spending enthusiasm cools — as it eventually will — a company that IPO'd at a hype-cycle peak gets punished far worse than one that waited for a sustainable valuation.

The most likely trigger is Arsenal-1 reaching production scale. Once Anduril can demonstrate mass manufacturing capacity — not just contracts, but actual delivery — the IPO story shifts from "promising defense startup" to "scaled defense prime," and the valuation multiple it commands on public markets changes entirely.

Bull Case vs. Bear Case

How to Get Exposure Before the IPO

Since Anduril is still private, retail investors cannot buy shares directly. Here are the realistic options for getting exposure to the company or the defense tech sector before an eventual public listing.

The Bottom Line on the Anduril IPO

Anduril is the rare company where the hype and the substance are both real. A $61 billion valuation sounds aggressive until you look at a $20 billion Army contract, near-100% revenue growth, and a product suite that the US military is actively deploying. The question is not whether the company can justify going public — it can — but whether public market investors will pay a premium over the last private round, or demand a discount for the lack of audited financials and the risks of government contract dependency.

I expect the IPO to happen in late 2026 or 2027, timed to Arsenal-1 reaching production milestones that demonstrate Anduril can manufacture at scale. When it does, it will likely be the largest defense IPO in decades and one of the largest tech IPOs of the year. The underwriter lineup will be a signal worth watching — when Goldman, Morgan Stanley, and JPMorgan start jockeying for the book, the filing is close.

For now, Anduril is a company to track, not to chase. The private market valuation has doubled in a year, which means the easy money has been made. The IPO money — and the real test of the thesis — is still ahead. Track it on the IPO Tracker, the Unicorn Tracker, and the rest of this year's listings on our Tech IPO Dashboard.